Agency says application rejected due to lack of ‘adequate and well controlled’ trial, but experts say ‘they’re just coming up with reasons’

A senior US Food and Drug Administration (FDA) official says Moderna’s clinical trial on a new, potentially more effective flu vaccine was a “brazen failure” and that the FDA is now calling it into question.

The FDA unexpectedly refused to consider Moderna’s application for a flu shot based on messenger RNA (mRNA) technology in a decision that experts say is already having a chilling effect on vaccine development.

Officials say the issue is the design of the study, in which control group participants over the age of 65 should have received a high-dose flu shot instead of a standard flu shot.

Outside experts say the reasons seem to go deeper. “It’s all pretext and obfuscation when the real agenda is rejecting conventional science and serving a predetermined anti-vaccine agenda,” said Richard Hughes IV, a partner with Epstein Becker Green and law professor at George Washington University.

  • EchoCranium@lemmy.zip
    link
    fedilink
    English
    arrow-up
    12
    ·
    3 days ago

    And funding cuts ended a lot of ongoing research projects. The US will be at least a decade behind in breakthroughs because we have morons in charge who value conspiracy theory over scientific method.

    • BarneyPiccolo@lemmy.today
      link
      fedilink
      arrow-up
      6
      ·
      3 days ago

      When we take our country back, we should force these rich hyenas to fund the repairs out of their personal fortunes. Whatever is left, gets confiscated to fund Universal Health Care and UBI. They won’t need it, they’ll all be in prison, if they’re lucky.

    • ramble81@lemmy.zip
      link
      fedilink
      arrow-up
      3
      ·
      3 days ago

      This will be interesting to see because one of the arguments I always hear about why our prescription prices are so much higher than the rest of the world is that “companies do their R&D here and need to recoup the cost”…. What’s going to be their excuse when companies pull out and we still have high prices.

      • EchoCranium@lemmy.zip
        link
        fedilink
        English
        arrow-up
        6
        ·
        3 days ago

        Those companies, like Pfizer, do very little of their R&D. They spend money buying up companies to control the IP after most of the work is done. And that work is often funded by government grants. So American citizens have their tax money go towards research (which is great, I’m all for that) but for-profit companies come in at the end to carry the ball over the line, and make billions doing it (which we pay for too). Broken system.